The Safety and Efficacy of Long-term Treatment of PINS Stimulator System for Tourette Syndrome

NCT02253498 · Status: UNKNOWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2016-10-14

No results posted yet for this study

Summary

The purpose of this clinical study is to verify the long term effectiveness and safety of a bilateral deep brain stimulation (DBS) produced by Beijing PINS Medical Co., Ltd. as a treatment option for patients with cognitive, behavioral, and functional disability of Tourette Syndrome.

Conditions

  • Tourette Syndrome

Interventions

DEVICE

deep brain stimulation (DBS)

Sponsors & Collaborators

  • Beijing Tiantan Hospital

    collaborator OTHER
  • Beijing Pins Medical Co., Ltd

    lead INDUSTRY

Principal Investigators

  • Li Luming, PhD · Tsinghua University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-31
Primary Completion
2018-12-31
Completion
2018-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02253498 on ClinicalTrials.gov